Context for CME Group after recent share performance

CME Group (CME) shares have eased in the month and past week, with returns of about a 2% decline over 30 days and a 1% decline over 7 days, while the past 3 months show a roughly 14% gain.

The recent 1 day and 30 day share price declines sit against a stronger backdrop, with the 90 day share price return of 13.9% and 1 year total shareholder return of 20.1% pointing to momentum that has built over a longer period.

If CME Group's recent moves have you thinking about where else capital is flowing, it could be a good time to scan 19 top founder-led companies

So with CME Group posting 3 year and 5 year total returns above 79% and annual revenue and net income growth in the mid single digits, is recent softness a fresh entry point, or has the market already priced in future growth?

Most Popular Narrative: 3% Undervalued

The most followed narrative pegs CME Group's fair value at about $306.86, slightly above the last close of $298.93. This frames the modest 2.6% discount as a tight valuation gap based on detailed long term assumptions.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

Curious what justifies that fair value uplift over today’s price? The narrative focuses on measured revenue growth, high margins, and a richer future earnings multiple. Want to see which specific long range forecasts tie all of that together.

Result: Fair Value of $306.86 (UNDERVALUED)

However, this hinges on volatility and volume holding up, provided that DeFi and lower fee venues do not siphon too much trading away from CME’s core contracts.

Another View: P/E Signals Less Room For Error

That 3% gap to fair value is one story, but the P/E tells another. CME trades on about 27x earnings, which sits below peers at 28.6x and the wider US Capital Markets group at 39.1x, yet well above its own fair ratio of 15.1x.

For you, that mix of a discount to peers and a premium to the fair ratio points to limited margin for disappointment, since even a small reset toward 15.1x would imply a very different outcome. Which of those reference points feels more realistic for the next few years?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CME Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 62 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on value and expectations, it helps to move quickly, check the numbers for yourself, and decide where you stand using the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If CME Group has sharpened your thinking, do not stop here. Use tailored stock ideas to widen your watchlist and avoid missing the next opportunity.

• Start building a watchlist of cash generative businesses by scanning the 62 high quality undervalued stocks that combine quality fundamentals with appealing prices.
• Strengthen your income stream by reviewing the 11 dividend fortresses that focus on higher yielding companies with an emphasis on resilience.
• Reduce portfolio stress by filtering for the 73 resilient stocks with low risk scores that highlight companies with more stable risk profiles and solid financial footing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.